bioAffinity, Pictor Collaborate on Asthma and COPD Tests
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
Read MoreNew research suggests acoustic speech features can identify respiratory exacerbations from the first day of onset.
Read MoreAsthma-COPD overlap syndrome (ACOS) accounts for approximately 15-25% of all obstructive airway diseases, but distinguishing between ACOS and asthma or COPD alone can be a challenging diagnosis.
Read More